CanadaBis Capital Inc

Healthcare CA CANB

0.045CAD
0.005(12.50%)

Last update at 2025-07-09T19:49:00Z

Day Range

0.040.04
LowHigh

52 Week Range

0.040.11
LowHigh

Fundamentals

  • Previous Close 0.04
  • Market Cap6.22M
  • Volume4862
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA1.00M
  • Revenue TTM17.89M
  • Revenue Per Share TTM0.13
  • Gross Profit TTM 8.50M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-07-31 2023-07-31 2022-07-31 2021-07-31 2020-07-31
Type yearly yearly yearly yearly yearly
Date 2024-07-31 2023-07-31 2022-07-31 2021-07-31 2020-07-31
Income before tax 0.68M 4.56M 0.61M -2.68091M -5.39108M
Minority interest 0.00000M 0.00000M 0.00038M 0.00414M 0.10M
Net income 0.60M 4.44M 0.61M -2.67677M -5.38878M
Selling general administrative 7.45M 6.76M 4.23M 4.48M 5.60M
Selling and marketing expenses - - - - -
Gross profit 8.82M 11.78M 5.57M 2.52M 1.16M
Reconciled depreciation 0.90M 0.67M 0.53M 0.47M 0.28M
Ebit - 5.01M 1.10M -2.28137M -5.06644M
Ebitda - 5.68M 1.63M -1.81245M -4.78472M
Depreciation and amortization - 0.67M 0.53M 0.47M 0.28M
Non operating income net other - - - - -
Operating income 0.83M 4.68M 1.04M -2.28565M -4.72004M
Other operating expenses - 17.55M 10.63M 9.15M 9.15M
Interest expense 0.51M 0.45M 0.49M 0.40M 0.32M
Tax provision 0.08M 0.12M 0.00000M - -
Interest income - - - - -
Net interest income -0.50985M -0.44611M -0.49263M -0.39954M -0.67637M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 0.12M 0.56M 0.40M 0.33M
Total revenue 17.95M 22.22M 11.67M 6.87M 4.43M
Total operating expenses 17.12M 7.11M 4.53M 4.80M 5.88M
Cost of revenue 9.13M 10.44M 6.10M 4.35M 3.27M
Total other income expense net 0.36M 0.33M 0.06M 0.00428M 0.00533M
Discontinued operations - - - - -
Net income from continuing ops 0.60M 4.44M 0.61M -2.68091M -5.39108M
Net income applicable to common shares - - 0.61M -2.67677M -5.38878M
Preferred stock and other adjustments - - - - -
Breakdown 2024-07-31 2023-07-31 2022-07-31 2021-07-31 2020-07-31
Type yearly yearly yearly yearly yearly
Date 2024-07-31 2023-07-31 2022-07-31 2021-07-31 2020-07-31
Total assets 24.55M 22.96M 15.48M 13.28M 12.52M
Intangible assets - - - 0.00771M 0.02M
Earning assets - - - - -
Other current assets - - 0.06M 0.03M 0.07M
Total liab 16.45M 15.62M 12.84M 11.46M 9.09M
Total stockholder equity 8.00M 7.25M 2.54M 1.73M 3.34M
Deferred long term liab - - - - -
Other current liab - - 0.77M 0.70M 0.59M
Common stock - - 16.15M 16.00M 15.39M
Capital stock 16.75M 16.73M 16.15M 16.00M 15.39M
Retained earnings -11.86782M -12.46811M -16.91260M -17.52094M -14.84416M
Other liab - - 0.04M 0.06M -
Good will - - - - -
Other assets - - 0.29M 0.29M 0.00643M
Cash 1.68M 3.23M 0.14M 0.85M 0.17M
Cash and equivalents - - - - -
Total current liabilities 11.91M 9.68M 11.90M 10.14M 7.73M
Current deferred revenue - - - - -
Net debt 3.76M 2.75M 7.08M 6.59M 5.49M
Short term debt - - - - -
Short long term debt 1.54M 1.01M 6.75M 6.99M 4.69M
Short long term debt total - - - - -
Other stockholder equity - - 3.31M 3.25M 2.80M
Property plant equipment - - 9.51M 10.09M 9.77M
Total current assets 13.72M 11.63M 5.68M 2.90M 2.73M
Long term investments - - - - -
Net tangible assets - - 2.54M 1.72M 3.32M
Short term investments - - - - -
Net receivables 1.98M 1.81M 2.14M 0.67M 1.31M
Long term debt 3.90M 4.97M 0.47M 0.46M 0.96M
Inventory 9.26M 5.83M 2.93M 1.22M 1.08M
Accounts payable 8.06M 6.43M 3.54M 1.33M 1.79M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 10.83M 11.33M 9.80M 10.38M 9.79M
Capital lease obligations 1.00M 1.33M 0.59M 1.00M 0.40M
Long term debt total - - - - -
Breakdown 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Type yearly yearly yearly yearly yearly
Date 2023-07-31 2022-07-31 2021-07-31 2020-07-31 2019-07-31
Investments -0.96582M -0.20977M 0.12M -2.38753M -1.95027M
Change to liabilities - 2.19M -0.61421M 0.84M 0.00076M
Total cashflows from investing activities - -0.20977M 0.12M -2.38753M -1.95027M
Net borrowings - -1.02849M 2.05M 4.54M -0.35731M
Total cash from financing activities -1.50170M -0.41209M 2.37M 5.85M 3.29M
Change to operating activities - -0.25120M 0.20M -0.14202M -0.52257M
Net income 4.44M 0.61M -2.67677M -5.38878M -9.00286M
Change in cash 3.08M -0.70463M 0.68M -0.15780M -0.35415M
Begin period cash flow 0.14M 0.85M 0.17M 0.32M 0.68M
End period cash flow 3.23M 0.14M 0.85M 0.17M 0.32M
Total cash from operating activities 5.55M -0.08277M -1.80666M -3.61932M -1.69470M
Issuance of capital stock 0.21M 0.15M 0.54M 1.28M 3.65M
Depreciation 0.67M 0.53M 0.47M 0.28M 0.06M
Other cashflows from investing activities - - 0.27M 0.58M 0.21M
Dividends paid 0.00000M 0.00000M - - -
Change to inventory -2.97840M -1.81286M -0.16640M -1.24076M -1.24076M
Change to account receivables 0.14M -1.46644M 0.40M -1.07234M -1.07234M
Sale purchase of stock - - - - -
Other cashflows from financing activities - -0.00105M -0.22500M 0.03M 0.03M
Change to netincome - 0.12M 0.58M 3.10M 7.77M
Capital expenditures 0.98M 0.21M 0.15M 4.96M 2.63M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.09M -1.33798M -0.15777M -0.95133M -0.67977M
Stock based compensation 0.05M 0.05M 0.46M 2.69M 3.33M
Other non cash items 0.13M 0.04M -0.02510M -0.24793M 4.59M
Free cash flow 4.57M -0.29254M -1.95899M -8.58483M -4.32828M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CANB
CanadaBis Capital Inc
0.005 12.50% 0.04 - - 0.35 0.74 0.61 6.63
RX
Biosyent Inc.
0.08 0.67% 11.98 18.58 15.70 3.82 3.65 3.34 11.28
LOVE
Cannara Biotech Inc
-0.07 3.70% 1.82 11.00 - 0.77 0.73 1.34 6.59
ZYUS
ZYUS Life Sciences Corporation
0.04 5.88% 0.72 - - 135.51 3.73 157.30 -4.258
LSL
LSL Pharma Group Inc.
- -% 0.40 - - 3.91 2.88 4.85 636.87

Reports Covered

Stock Research & News

Profile

CanadaBis Capital Inc. engages in the production and sale of recreational cannabis and cannabis extracts in Canada. It operates through three segments: cultivation and wholesale, retail, and extract. The company cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. It is also involved in the sale of cannabis and cannabis related products to end consumers on premise owned and operated by the company; and wholesale extract products to distributors and licensed cannabis producers. CanadaBis Capital Inc. was formerly known as 1926360 Alberta Ltd. and changed its name to CanadaBis Capital Inc. in April 2019. The company was incorporated 2016 and is based in Red Deer County, Canada.

CanadaBis Capital Inc

255C Clearview Drive, Red Deer County, AB, Canada, T4E 3B6

Key Executives

Name Title Year Born
Mr. Travis Gerald McIntyre Pres, CEO & Director 1981
Mr. Shane Chana C.A., CPA CFO & Director 1986
Ms. Barbara O'Neill Corp. Sec. & Director 1967
Mr. Travis Gerald McIntyre President, CEO & Director 1981
Mr. Garfield Richards C.A., CPA Chief Financial Officer NA
Ms. Barbara Michele O'Neill Corporate Secretary & Director 1967
Mr. Shane Chana C.A., CPA Director & Interim CFO 1986

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.